Kabaeva, Zhyldyz: Genetic analysis in hypertrophic cardiomyopathy: missense mutations in the ventricular myosin regulatory light chain gene

63

References

1. Richardson P, McKenna W, Bristow M et al. "Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies." Circulation 1996; 93: 841-2.

2. Seidman JG, Seidman C. "The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms." Cell 2001; 104: 557-67.

3. Marian AJ and Robertrs R. "The molecular genetic basis for cardiomyopathy. " J Mol Cell Cardiol 2001; 33 : 655-70.

4. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. "Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. " Circulation 1995; 92 : 785-9 .

5. Maron BJ, Olivotto I, Spirito P et al. "Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population." Circulation 2000; 102: 858-64.

6. Teare RD. "Asymmetrical hypertrophy of the heart in young adults." Br Heart 1958; 20: 1-8.

7. Geisterfer-Lowrance AA, Kass S, Tanigawa G et al. "A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation." Cell 1990; 62: 999-1006 .

8. Thierfelder L, Watkins H, MacRae C et al. "Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere." Cell 1994; 77: 701-12.

9. Watkins H, Conner D, Thierfelder L et al. "Mutations in the cardiac myosin binding "


64

"protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy." Nat Genet 1995; 11: 434-7.

10. Poetter K, Jiang H, Hassanzadeh S et al. "Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle." Nat Genet 1996; 13: 63-9.

11. Kimura A, Harada H, Park JE et al. "Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. " Nat Genet 1997; 16: 379-82 .

12. Mogensen J, Klausen IC, Pedersen AK et al. "Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy." J Clin Invest 1999; 103: R39-43.

13. Satoh M, Takahashi M, Sakamoto T, Hiroe M, Marumo F, Kimura A. "Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. " Biochem Biophys Res Commun 1999; 262: 411-7 .

14. Fung DC, Yu B, Littlejohn T, Trent RJ. "An online locus-specific mutation database for familial hypertrophic cardiomyopathy. " Hum Mutat 1999; 14: 326-32.

15. Flavigny J, Richard P, Isnard R et al. "Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy. " J Mol Med 1998; 76: 208-14.

16. Andersen PS, Havndrup O, Bundgaard H et al. "Myosin light chain mutations in familial hypertrophic cardiomyopathy: phenotypic presentation and frequency in Danish and South African populations." J Med Genet 2001; 38: E43.

17. Dalloz F, Osinska H, Robbins J. "Manipulating the contractile apparatus: genetically defined animal models of cardiovascular disease." J Mol Cell Cardiol 2001; 33: 9-25.

18. Marian AJ, Wu Y, Lim DS et al ". A transgenic rabbit model for human hypertrophic cardiomyopathy." J Clin Invest 1999; 104: 1683-92.

19. Seiler SH, Fischman DA, Leinwand LA. "Modulation of myosin filament organization by C-protein family members." Mol Biol Cell 1996; 7: 113-27.

20. Harrison‘s principles of internal Medicine. 14th edition . Fauci AS, Braunwald E, Isselbacher KJ et al. USA 1998; chapter 232: p1279.

21. Rayment I, Rypniewski WR, Schmidt-Base K et al. "Three-dimensional structure of myosin subfragment-1: a molecular motor." Science 1993; 261: 50-8.


65

22. Mulvihill DP and Hyams JS. "Shedding a little light on light chains." Nature Cell Biology 2001 ; 3 :E1-2.

23. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Molecular biology of the cell. 3nd ed. USA 1994; chapter 16: pp 847-858.

24. Marian AJ. Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet 2000; 355: 58-60.

25. Macera MJ, Szabo P, Wadgaonkar R, Siddiqui MA, Verma RS. "Localization of the gene coding for ventricular myosin regulatory light chain (MYL2) to human chromosome 12q23-q24.3. " Genomics 1992; 13: 829-31.

26. Fodor WL, Darras B, Seharaseyon J, Falkenthal S, Francke U, Vanin EF . "Human ventricular/slow twitch myosin alkali light chain gene characterization, sequence, and chromosomal location. " Nature 1985; 315: 37-40.

27. Babu YS, Sack JS, Greenhough, Bugg cE, Means AR, Cook WJ. "Three-dimensional structure of calmodulin." J Biol Chem 1989; 264: 2143-9.

28. daSilva AC, Reinach FC. "Calcium binding induces conformational changes in muscle regulatory proteins." Trends Biochem Sci 1991; 16: 53-7.

29. Szczesna D, Ghosh D, Li Q et al. "Familial hypertrophic cardiomyopathy mutations in the regulatory light chains of myosin affect their structure, Ca2+ binding, and phosphorylation." J Biol Chem 2001 ; 276: 7086-92 .

30. Morano I. "Tuning the human heart molecular motors by myosin light chains." J Mol Med 1999; 77: 544-55.

31. Uyeda TQ, Abramson PD, Spudich JA. "The neck region of the myosin motor domain acts as a lever arm to generate movement. " Proc Natl Acad Sci U S A 1996; 93: 4459-64.

32. Lowey S, Waller GS, Trybus KM. "Skeletal muscle myosin light chains are essential for physiological speeds of shortening." Nature 1993; 365: 454-6.

33. Lowey S, Trybus KM. "Role of skeletal and smooth muscle myosin light chains. " Biophys J 1995; 68: 120S-127S .

34. Trybus KM . "Role of myosin light chains." J Muscle Res Cell Motil 1994; 15: 587-94.


66

35. Sweeney HL, Stull JT . "Alteration of cross-bridge kinetics by myosin light chain phosphorylation in rabbit skeletal muscle: implications for regulation of actin-myosin interaction." Proc Natl Acad Sci U S A 1990; 87: 414-8.

36. Sweeney HL, Bowman BF, Stull JT . "Myosin light chain phosphorylation in vertebrate striated muscle: regulation and function." Am J Physiol 1993; 264: C1085-95.

37. Levine RJ, Kensler RW, Yang Z, Sweeney HL. "Myosin regulatory light chain phosphorylation and the production of functionally significant changes in myosin head arrangement on striated muscle thick filaments." Biophys J 1995; 68: 224S .

38. Levine RJ, Kensler RW, Yang Z, Stull JT, Sweeney HL. "Myosin light chain phosphorylation affects the structure of rabbit skeletal muscle thick filaments. " Biophys J 1996; 71: 898-907 .

39. Szczesna D, Zhao J, Guzman G, Zhi G, Stull D, Potter JD. "Phosphorylation and Ca2+ binding to the regulatory light chains of myosin in the regulation of skeletal muscle contraction." Biophys J 1997; 72: A175.

40. Roberts R, Sigwart U. "New concepts in hypertrophic cardiomyopathies, part II." Circulation 2001 ; 104: 2249-52.

41. Wigle ED . Cardiomyopathy: "The diagnosis of hypertrophic cardiomyopathy." Heart 2001; 86: 709-14.

42. Heart Disease. A textbook of cardiovascular Medicine. 5th edition. Braunwald E . USA 1997 ; chapter 41: p 1421.

43. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M. "Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families." Heart 1997; 77: 130-2.

44. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. "Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy." N Engl J Med 2000; 342: 1778-85.

45. Maron BJ, Gottdiener JS, Epstein SE. "Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients." Am J Cardiol 1981; 48: 418-28.

46. Elliott PM, Poloniecki J, Dickie S et al. "Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. " J Am Coll Cardiol 2000; 36: 2212-8.


67

47. Maron BJ. "Ventricular arrhythmias, sudden death, and prevention in patients with hypertrophic cardiomyopathy." Curr Cardiol Rep 2000; 2: 522-8.

48. Fatkin D, Graham RM. "Prognostic value of left ventricular hypertrophy in hypertrophic cardiomyopathy." N Engl J Med 2001 ; 344: 63-5.

49. Elliott PM, Gimeno Blanes JR, Mahon NG, Poloniecki JD, McKenna WJ. "Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy." Lancet 2001; 357: 420-4.

50. Tesson F, Richard P, Charron P et al. "Genotype-phenotype analysis in four families with mutations in beta-myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy." Hum Mutat 1998; 12: 385-92.

51. Charron P, Dubourg O, Desnos M et al . "Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes." Eur Heart J 1998; 19: 139-45.

52. Charron P, Dubourg O, Desnos M et al. "Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene." Circulation 1998; 97: 2230-6.

53. Watkins H, McKenna WJ, Thierfelder L et al. "Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy." N Engl J Med 1995; 332 : 1058-64.

54. Hwang TH, Lee WH, Kimura A et al. "Early expression of a malignant phenotype of familial hypertrophic cardiomyopathy associated with a Gly716Arg myosin heavy chain mutation in a Korean family." Am J Cardiol 1998; 82: 1509-13.

55. Erdmann J, Raible J, Maki-Abadi J et al. "Spectrum of clinical phenotypes and gene variants in cardiac myosin-" binding protein C mutation carriers with hypertrophic cardiomyopathy. J Am Coll Cardiol 2001; 38: 322-30.

56. Maron BJ ". Hypertrophic cardiomyopathy." Lancet 1997; 350: 127-33.

57. Ortlepp JR, Vosberg HP, Reith S et al. "Genetic polymorphisms in the rennin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene." Heart 2002 ; 87: 270-275.


68

58. Roberts R, Sigwart U. "New concepts in hypertrophic cardiomyopathies, part I" . Circulation 2001; 104: 2113-16 .

59. Lee WH, Hwang TH, Kimura A et al. "Different expressivity of a ventricular essential myosin light chain gene Ala57Gly mutation in familial hypertrophic cardiomyopathy." Am Heart J 2001; 141: 184-9.

60. Henry WL, DeMaria A, Gramiak R et al . "Report of the american society of echocardiography committee on nomenclature and standards in two-dimensional echocardiography." Circulation 1980 ; 62: 212-5.

61. Henry WL, Gardin JM, Ware JH. "Echocardiographic measurements in normal subjects from infancy to old age." Circulation 1980; 62: 1054-61.

62. Lahiri DK, Nurnberger JI. "A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies." Nucleic Acids Res 1991 ; 19: 5444 .

63. Hayashi K, Yandell DW. "How sensitive is PCR-SSCP?" Hum Mutat 1993 ; 2: 338-46.

64. Condie A, Eeles R, Borresen AL, Coles C, Cooper C, Prosser J. "Detection of point mutations in the p53 gene: comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques." Hum Mutat 1993; 2: 58-66.

65. Dunnen JT and Antonarakis SE. "Mutation nomenclature extensions and suggestions to describe complex mutations. " Hum Mutat 2000; 15: 7-12.

66. Miura K, Nakagawa H, Morikawa et al. "Epidemiology of idiopathic cardiomyopathy in Japan: results from nationwide survey." Heart 2002 ; 87: 126-30.

67. Grompe M. "The rapid detection of unknown mutations in nucleic acids." Nat Genet 1993 ; 5: 111-7.

68. Orita M, Suzuki Y, Sekiya T, Hayashi K. "Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction." Genomics 1989 ; 5: 874-9.

69. Glavac D, Dean M. "Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutations." Hum Mutat 1993; 2: 404-14.

70. Lewis R. "SNPs as windows on evolution" . The Scientist 2002 ; 16: 16-18.


69

71. Syvanen AC, Landegren U, Isaksson A, Gyllensten U, Brookes A. First International SNP Meeting at Skokloster, Sweden, August 1998. "Enthusiasm mixed with scepticism about single-nucleotide polymorphism markers for dissecting complex disorders." Eur J Hum Genet 1999; 7: 98-101.

72. Sachidanandam R, Weissman D, Schmidt SC et al. "A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms." Nature 2001 ; 409 : 928-33.

73. Geraghty DE, Vu Q, Williams L et al. "Mapping HLA for single nucleotide polymorphisms." Rev Immunogenet 1999 ; 1: 231-8.

74. Martin ER, Lai EH, Gilbert JR et al. "SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease." Am J Hum Genet 2000 ; 67: 383-94.

75. Herrmann S, Schmidt-Petersen K, Pfeifer J et al. "A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy." Eur Heart J 2001 ; 22: 1948-53.

76. Charron P, Carrier L, Dubourg O et al. "Penetrance of familial hypertrophic cardiomyopathy" . Genet Couns 1997 ; 8: 107-14.

77. Moolman JC, Corfield VA, Posen B et al. "Sudden death due to troponin T mutations." J Am Coll Cardiol 1997 ; 29: 549-55.

78. Maron BJ, Niimura H, Casey SA et al. "Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations" . J Am Coll Cardiol 2001 ; 38: 315-21.

79. Ko YL, Chen JJ, Tang TK et al. "Malignant familial hypertrophic cardiomyopathy in a family with a 453Arg-Cys mutation in the ß-myosin heavy chain gene: coexistence of sudden death and end-stage heart failure. " Hum Gen 1996; 97: 585-90.

80. Levine RJ, Yang Z, Epstein ND, Fananapazir L, Stull JT, Sweeney HL. "Structural and functional responses of mammalian thick filaments to alterations in myosin regulatory light chains. " J Struct Biol 1998 ; 122: 149-61.

81. Sweeney HL, Yang Z, Zhi G, Stull JT, Trybus KM. "Charge replacement near the phosphorylatable serine of the myosin regulatory light chain mimics aspects of phosphorylation" . Proc Natl Acad Sci Usa 1994; 91: 1490-94.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.

DiML DTD Version 2.0
Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML - Version erstellt am:
Mon Jan 6 12:37:59 2003